Rinvoq ER 45 MG tablet UU 28S
Ended Awarded
- Contract number
- SPE2DB25FX40T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,888
Award facts
- Contract value 100% obligated
- $31,887.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $31,887.66 to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of RINVOQ ER 45 mg tablets (28-count units). This firm fixed-price, non-competitive delivery order is set to be completed by September 5, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. RINVOQ (upadacitinib) is a Janus kinase inhibitor used to treat rheumatoid arthritis and other inflammatory conditions, reflecting the Defense Logistics Agency Medical Supply Chain's ongoing procurement of specialized pharmaceuticals to support military and veteran healthcare systems.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and prime vendor for federal medical procurement, AmerisourceBergen Drug Corp leverages this comprehensive contract vehicle to supply an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's designation as a child contract under this prime indefinite delivery vehicle enables efficient fulfillment of individual delivery orders such as this RINVOQ procurement to support military healthcare requirements.
Quick answers
Who was awarded contract SPE2DB25FX40T?
SPE2DB25FX40T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FX40T worth?
The government has obligated $31,888 on SPE2DB25FX40T.
Is contract SPE2DB25FX40T an order under another contract?
Yes. SPE2DB25FX40T is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FX40T competed?
The extent of competition for SPE2DB25FX40T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award